Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
- Disease/Condition
- Epilepsy
- Drug/Device/Intervention
- Pharmacist-led Cognitive Behavioral therapy
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Hamdard University
- Location
- Islamabad, Pakistan
- Phase
- N/A
- Start date
- Sep 22, 2023
- End date
- Mar 15, 2024
- Enrollment
- 385 participants
Medication adherence,Quality of life of Epileptic patients
The purpose of this interventional study is to assess the impact of pharmacist-led cognitive
 behavioral intervention in epileptic patients. The main questions are:
 
 1. If pharmacist-led cognitive behavioral therapy can help in improving patient medication
 adherence?
 
 2. How will the cognitive behavioral therapy impact the quality of life of the patients?
 
 Participants of this study will be provided basic or advanced level counselling and
 educational material as part of their routine pharmacy visit.
 
 Researchers will compare the two groups (Basic and advanced) to see which of the two groups
 are better in term of medication adherence and quality of life.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06034353
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06034353 through Pure Global AI's free database. This phase not specified trial is sponsored by Hamdard University and is currently Recruitment Completed. The study focuses on Epilepsy. Target enrollment is 385 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.